These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 16193700)

  • 1. Target intraocular pressure in the management of glaucoma.
    Popović-Suić S; Sikić J; Vukojević N; Cerovski B; Nasić M; Pokupec R
    Coll Antropol; 2005; 29 Suppl 1():149-51. PubMed ID: 16193700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical approach to normal intraocular pressure glaucoma].
    Cerovski B; Popović Suić S; Bujger Z; Miljenka T; Cerovski J
    Acta Med Croatica; 2005; 59(2):123-8. PubMed ID: 15909886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing vision loss from glaucoma: putting data from clinical trials into practice.
    Schoenleber DB
    Mo Med; 2005; 102(1):51-4. PubMed ID: 15754618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When should the anti-glaucoma treatment start?].
    Nordmann JP
    J Fr Ophtalmol; 2001 Dec; 24(10):1092-4. PubMed ID: 11913241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early aggressive intraocular pressure lowering, target intraocular pressure, and a novel concept for glaucoma care.
    Singh K; Shrivastava A
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S33-8. PubMed ID: 19038622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four hour ocular perfusion pressure fluctuation and risk of normal-tension glaucoma progression.
    Sung KR; Lee S; Park SB; Choi J; Kim ST; Yun SC; Kang SY; Cho JW; Kook MS
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5266-74. PubMed ID: 19474398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean intraocular pressure and progression based on corneal thickness in patients with ocular hypertension.
    Konstas AG; Irkec MT; Teus MA; Cvenkel B; Astakhov YS; Sharpe ED; Hollo G; Mylopoulos N; Bozkurt B; Pizzamiglio C; Potyomkin VV; Alemu AM; Nasser QJ; Stewart JA; Stewart WC
    Eye (Lond); 2009 Jan; 23(1):73-8. PubMed ID: 17917683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some clinical implications of the collaborative normal tension glaucoma study.
    Drance SM
    Klin Oczna; 2004; 106(4-5):588-92. PubMed ID: 15646475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of normal-tension glaucoma.
    Desai PV; Caprioli J
    Prog Brain Res; 2008; 173():195-210. PubMed ID: 18929110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Normal-pressure glaucoma].
    Flammer J
    Fortschr Ophthalmol; 1990; 87 Suppl():S187-9. PubMed ID: 2083901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to conduct glaucoma therapy when pressure stays high despite topical treatment?].
    Nordmann JP
    J Fr Ophtalmol; 2003 Oct; 26 Spec No 2():S53-5. PubMed ID: 14646833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleral edge, not optic disc or retina, is the primary site of injury in chronic glaucoma.
    Hasnain SS
    Med Hypotheses; 2006; 67(6):1320-5. PubMed ID: 16824694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Currents on target intraocular pressure and intraocular pressure fluctuations in glaucoma management.
    Detry-Morel M
    Bull Soc Belge Ophtalmol; 2008; (308):35-43. PubMed ID: 18700453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical assessment. Clinical evaluation of normal-tension glaucoma].
    Valtot F
    J Fr Ophtalmol; 2005 Jun; 28 Spec No 2():2S25-2S30. PubMed ID: 16208237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma: early detection and therapy for prevention of vision loss.
    Rosenberg LF
    Am Fam Physician; 1995 Dec; 52(8):2289-98, 2303-4. PubMed ID: 7484722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.